AMAG Pharmaceuticals
AMAG
AMAG was delisted on the 13th of November, 2020.
182 hedge funds and large institutions have $900M invested in AMAG Pharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 62 increasing their positions, 58 reducing their positions, and 15 closing their positions.
67% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 15
5% more funds holding
Funds holding: 173 → 182 (+9)
7% more repeat investments, than reductions
Existing positions increased: 62 | Existing positions reduced: 58
0% more capital invested
Capital invested by funds: $898M → $900M (+$1.74M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
47% less call options, than puts
Call options by funds: $6.38M | Put options by funds: $12.1M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
+$4.81M |
| 2 |
JSP
Jackson Square Partners
Larkspur,
California
|
+$3.6M |
| 3 |
Nomura Holdings
Tokyo,
Japan
|
+$3.43M |
| 4 |
BlackRock
New York
|
+$2.52M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$2.18M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Russell Investments Group
London,
United Kingdom
|
-$14.4M |
| 2 |
FPC
Falcon Point Capital
San Francisco,
California
|
-$10.4M |
| 3 |
JP Morgan Chase
New York
|
-$8.19M |
| 4 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
-$3.57M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.94M |
AMAG Hedge Fund Activity: Q3 2018 in Review
182 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in AMAG Pharmaceuticals (AMAG) for Q3 2018, worth a combined $900M — up 0.19% from $898M a quarter earlier.
Buyers outnumbered sellers: 25 funds opened new AMAG positions and 15 closed out — a net gain of 10 holders — while 62 added to existing stakes and 58 trimmed.
The largest buyer was Invesco, adding an estimated $4.81M. The largest seller was Russell Investments Group, cutting an estimated $14.4M.
- 182 institutional investors held AMAG Pharmaceuticals (AMAG) as of Q3 2018, up from 173 in Q2 2018.
- Funds reported $900M of AMAG Pharmaceuticals stock for Q3 2018, up 0.19% quarter-over-quarter.
- 25 funds opened new AMAG Pharmaceuticals positions in Q3 2018 and 15 closed out, a net change of +10 holders.
- The largest AMAG Pharmaceuticals buyer in Q3 2018 was Invesco, an estimated $4.81M added.
- The largest AMAG Pharmaceuticals seller in Q3 2018 was Russell Investments Group, an estimated $14.4M sold.
Based on aggregated 13F filings for Q3 2018.